|
 Chintan Shivir held in Hyderabad on the pharma sector recently discussed role of the Export Promotion Mission (EPM) in empowering MSMEs for global markets, the effective utilisation of Free Trade Agreements (FTAs) signed by India to boost pharma exports, and the importance of the Trade Connect e-platform to explore the markets abroad.
The Hyderabad Chintan Shivir also highlighted the need for continued modernization of India’s regulatory frameworks, reduction of procedural bottlenecks, and bolstering innovation to tap into emerging global market opportunities.
The Event organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil), with the support of the Ministry of Commerce empahasized the evolving role of the Directorate General of Foreign Trade (DGFT) in promoting exports and ensuring alignment with global standards.
Furthermore, stakeholders deliberated on strategies for enhancing pharmaceutical exports, with an emphasis on improving regulatory compliance, expanding market access, and strengthening government support to elevate India’s pharmaceutical export footprint.
The event featured focused sessions on key areas of strategic importance, including the impact of artificial intelligence and digital transformation on global harmonisation in pharmaceutical regulatory affairs, where industry experts explored how AI and digital tools can streamline regulatory processes, enhance compliance, and support India’s push for greater market access.
“Despite current challenges such as supply chain stress and the geopolitical disruptions, India's export sector remains resilient, with positive growth trends. The Pharmexcil Chintan Shivir deliberated on the roadmap for the coming years. The event outlined a strategic vision for the pharmaceutical sector, emphasizing value creation through innovation and enhanced market access via FTAs. With ongoing policy support and a forward-looking approach, we are confident in achieving a successful conclusion to the financial year,” said Namit Joshi, chairman, Pharmexcil.
Commerce secretary Rajesh Agrawal highlighted that India’s pharmaceutical industry is uniquely positioned to strengthen its global leadership by deepening collaboration with the government and progressively reducing supply chain dependencies in a rapidly evolving and geopolitically dynamic global environment. “Building on its strong foundation of cost competitiveness, the next phase of growth lies in elevating India’s position as a trusted global benchmark for quality and reliability. By continuously strengthening the ecosystem and staying aligned with global advancements, the industry is well on track to transition towards high-value segments such as biologics and biosimilars,” he added.
“Indian pharmaceutical exports reached nearly USD 28.29 billion by February this financial year, growing 5.6% compared to last year. The sector, valued at approximately USD 60 billion, is projected to reach USD 130 billion by 2030. Despite global challenges, pharmaceutical exports have maintained strong momentum, with a 5.6% growth during April to February FY26,” said Raja Bhanu, director general (DG), Pharmexcil.
Pharmexcil also provided an update on its flagship event, iPHEX 2026, which will showcase India’s pharmaceutical manufacturing strengths, emphasizing innovation, higher-value offerings, and enhanced compliance standards. As global markets continue to shift towards complex generics and biosimilars, IPHEX 2026 will serve as a platform for exploring new business opportunities and reinforcing India’s role as a reliable global pharmaceutical partner.
The Chintan Shivir in Hyderabad concluded on a high note, with stakeholders across the pharmaceutical sector agreeing that continued collaboration between the government and industry is key to achieving India’s ambitious export growth goals.
Key dignitaries present at the Chintan Shivir, Hyderabad included Mohit Yadav, joint secretary, Department of Commerce and Industry, Ministry of Commerce and Industry, Satyaprakash T L, joint secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers and Nipun Jain, chairman of iPHEX 2026.
|